EUCTR2014-003725-17-PL进行中（未招募）不适用
A Phase 2b, Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Tralokinumab in Adult Subjects with Moderate-to-Severe Atopic Dermatitis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 184
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Age 18-75 years
- •- Physician diagnosis of atopic dermatitis for > 1 year
- •- Atopic dermatitis involvement of = 10% body surface area
- •- EASI score of = 12
- •- SCORAD of = 25
- •- IGA score of = 3
- •- Effective birth control in line with protocol details
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 160
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 24
排除标准
- •- History of anaphylaxis following any biologic therapy
- •- Hepatitis B, C or HIV
- •- Pregnant or breastfeeding
- •- History of cancer
- •- Previous receipt of tralokinumab
研究者
相似试验
进行中（未招募）
1 期
Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults with Atopic DermatitisMedDRA version: 19.0Level: LLTClassification code 10003639Term: Atopic dermatitisSystem Organ Class: 100000004858Atopic DermatitisEUCTR2014-003725-17-DEMedImmune184
进行中（未招募）
1 期
A controlled clinical trial to study RM-131 (relamorelin) in patients with vomiting symptoms and diabetic gastroparesisVomiting symptoms in patient with moderate to severe diabetic gastroparesisMedDRA version: 17.1Level: PTClassification code 10051153Term: Diabetic gastroparesisSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2014-005623-27-BERhythm Pharmaceuticals, Inc.395
进行中（未招募）
1 期
A double-blind, placebo-controlled Clinical Trial to evaluate the Safety and Efficacy of JNJ-64304500 in patients with Moderately to Severely Active Crohn’s DiseaseEUCTR2016-000634-21-HUJanssen-Cilag International NV693
进行中（未招募）
1 期
A study to investigate the effects of lumicitabine (JNJ-64041575) in hospitalized adults infected with human metapneumovirusHuman metapneumovirus infectionMedDRA version: 20.0Level: PTClassification code 10066226Term: Metapneumovirus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2017-001696-22-SEJanssen-Cilag International NV180
进行中（未招募）
1 期
A Phase 2b study for adults hospitalized with Respiratory Syncytial Virus.MedDRA version: 20.1Level: PTClassification code 10061603Term: Respiratory syncytial virus infectionSystem Organ Class: 10021881 - Infections and infestationsRespiratory Syncytial Virus InfectionEUCTR2016-001653-40-PLJanssen-Cilag International NV216